State Medicaid Outpatient Drug Spending and Prescription Counts

United States state-level data tracks covered outpatient drugs paid for by Medicaid agencies. The dataset includes drug name, National Drug Code, number of prescriptions, and dollars reimbursed per state. It supports analysis of pharmaceutical utilization and spending patterns within the Medicaid program.

Use Cases

• Analyzing state-level variations in prescription drug costs based on reimbursement dollars.
• Tracking utilization trends for specific drugs using prescription counts and National Drug Codes.
• Monitoring pharmaceutical spending within the Medicaid program over time.

Strengths

• Data is reported by all U.S. states participating in the Medicaid Drug Rebate Program.
• Covers the period since the start of the Medicaid Drug Rebate Program, indicating a long time series.

Limitations

• Key metadata such as row count, specific column names, and exact time range are not provided in the input.
• There is a conflict in the license metadata between 'other-license-specified' and 'us-pd' across different platform entries.

Provenance

Source

U.S. Department of Health & Human Services, via state Medicaid agencies.

Collection Method

Reported by states for covered outpatient drugs under the Medicaid Drug Rebate Program.

Time Range

Since the start of the Medicaid Drug Rebate Program (specific start year not provided).

Freshness

Last updated metadata indicates 2026-04-08, but this appears to be a future date and may be a system artifact.

Geography

United States, with state-level granularity.